Key facts
- Notable investors include Texas Medical Center, Mercury Fund, PharmStars, MoreThan Capital, Create Health Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for OmniScience
- ·The full record, as it builds
Funding rounds
No funding rounds for OmniScience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About OmniScience
Developer of an AI driven clinical intelligence platform designed to unify trial data and support faster, more confident clinical development decisions. The company's platform offers agentic AI oversight, unified live trial data, and explainable real time insights, enabling clinical development teams to manage trials more efficiently and deliver better outcomes for patients.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2017
- Employees
- 30
- Website
- omniscience.bio/
- Ownership
- Privately Held (backing)
OmniScience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in OmniScience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on OmniScience in its N-PORT filings yet. We sweep new filings monthly.